![Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals | Hovione Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals | Hovione](https://www.hovione.com/sites/default/files/styles/half_width_scaled/public/assets/images/dispersome_header_hovione.png?itok=Gr-CWhR7)
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals | Hovione
![Effect of dehydration pathway on the surface properties of molecular crystals - CrystEngComm (RSC Publishing) DOI:10.1039/D1CE00539A Effect of dehydration pathway on the surface properties of molecular crystals - CrystEngComm (RSC Publishing) DOI:10.1039/D1CE00539A](https://pubs.rsc.org/image/article/2021/CE/d1ce00539a/d1ce00539a-f1_hi-res.gif)
Effect of dehydration pathway on the surface properties of molecular crystals - CrystEngComm (RSC Publishing) DOI:10.1039/D1CE00539A
![Zerion Pharma ApS extends its licensing agreement with Rousselot B.V to exploit Dispersome® technology platform | Zerion Pharma Zerion Pharma ApS extends its licensing agreement with Rousselot B.V to exploit Dispersome® technology platform | Zerion Pharma](https://uploads-ssl.webflow.com/60e47ecf13750467c36eb8e6/619d353e609e0d9242323c39_pill-close-up.jpg)